PDA

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 [20] 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
  1. First Edition: December 7, 2011
  2. Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breas
  3. Combination treatment extends lives of women with metastatic breast cancer
  4. Women & Infants the first to offer digital breast tomosynthesis in southeastern New E
  5. State roundup: Aetna suing over Mich. BCBS hospital deals; ACLU threatens Ohio aborti
  6. Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-p
  7. Notch inhibitor appears to treat breast cancer
  8. Combination of two anti-estrogen drugs extends survival time of women with breast can
  9. Adjuvant zoledronic acid shows promise against ER-positive premenopausal breast cance
  10. Heart patients may experience fewer traumas with new invention
  11. Considering varying extent to which genes are turned on or off can help develop perso
  12. Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovar
  13. Study raises questions about breast cancer therapy
  14. Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal
  15. Breast cancer risks and management updates
  16. Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple ne
  17. Report uncovers disparities in cancer incidence and death rates in Australia
  18. MRI can predict breast cancer prognosis
  19. Ovary removal in younger women may lead to low-bone mineral density, arthritis
  20. VDF, CDC and VDC to educate women about gender-specific DVT risks
  21. Initial results from whole-genome sequencing trial for triple negative breast cancer
  22. Patients having stray tumor cells in the blood should receive aggressive treatment
  23. Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Ant
  24. ZEN bust-enhancing supplements may increase risk of breast cancer
  25. Trastuzumab improves long-term outcomes in obese patients with HER2-positive breast c
  26. Breast cancer hope with new drug and new combination regimens
  27. Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC
  28. Many postmenopausal women quit breast cancer drugs early because of side effects
  29. People in Northern Ireland less likely to develop cancers
  30. Study describes miR-124 can prevent and treat liver cancer
  31. HER2 proteins do not predict breast cancer patient's outcome after Herceptin treatmen
  32. Obese women with early-stage HER2-positive breast cancer may have poorer outcomes
  33. Researchers shown how BRCA1 inactivation raises cancer risk
  34. Syndax announces data from entinostat phase 2 study on HL
  35. Chemotherapy can cause cognitive problems in breast cancer survivors
  36. Side effects and non-compliance with breast cancer therapy
  37. Risk of breast cancer in the genetically predisposed
  38. Bone drug effective in improving breast cancer survival
  39. Geron commences GRN1005 Phase 2 trial in breast cancer
  40. Synta's ganetespib shows potent in vitro and in vivo activity against multiple breast
  41. Aethlon Hemopurifier can capture Nef protein exosomes linked with HIV
  42. Cancer screening: Is it necessary in the elderly?
  43. DCC gene protects mice from onset of colon cancer
  44. Dana-Farber Cancer Institute introduces Insight blog
  45. Potential breakthrough test would predict breast cancer progression, recurrence
  46. Hologic receives FDA approval for Cervista HTA system to detect cervical cancer
  47. Researchers discover miR-520 blocks cancer-promoting signaling pathway
  48. Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carc
  49. MDA doctors challenge breast cancer brachytherapy study
  50. Bloomberg TV to air segment on Antigen Express' immunotherapeutic breast cancer vacci
  51. Tufts professor receives IEEE Fellow designation
  52. SonoCiné AWBU effective in detecting small cancers not detectable with mammography
  53. Mammography appears to detect women with low-risk breast cancer
  54. Women with breast cancer more likely to develop heart disease
  55. SMA honors JSUMC obstetrician with Robert D. and Alma W. Moreton Original Research Aw
  56. Optical imaging can visualize cultured cancer cells' response to particular drug
  57. Fear of cancer spurs breast implant recall
  58. Researchers discover how normal cells in tumors can drive cancer growth
  59. Memorial Sloan-Kettering Cancer Center joins The Robertson Foundation
  60. Consistent evidence that HRT use associated with breast cancer
  61. Oncologists present results from studies on relapse of breast cancer
  62. Show Your Logo supports fight against breast cancer
  63. Glycol chitosan-coated MRI agent safer, more effective in detecting breast cancer
  64. Harvard Medical Review 2011 ReCap
  65. New initiative to detect cancers in earliest stages inside cells
  66. GOG targeted therapy phase 3 clinical trial delays progression of advanced ovarian ca
  67. Free, low-cost strategies to maintain good health in the new year
  68. Venezuela offers to pay for removal of faulty breast implants
  69. Meditation, yoga and physical awareness benefit breast cancer survivors
  70. FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prosta
  71. New report on CNS, metabolic, immunologic disorders, infection, cardiovascular diseas
  72. CHEST Foundation awards $100,000 for development of blood test for lung cancer
  73. iCAD enters $15M debt facility agreement with Deerfield Management
  74. CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer
  75. PIP breast implant update
  76. Alteration in ISG15 pathway triggers breast cancer metastasis
  77. Antigen Express to move AE37 cancer vaccine into larger clinical trials
  78. PEDF may suppress brain from tumor-induced damage, metastasis
  79. Lithocholic acid can kill several types of cancer cells
  80. Antiestrogen supplements may reduce risk of melanoma in women with breast cancer
  81. ACS report shows decline in overall cancer death rates
  82. Daily doses of S-equol reduce hot flashes in postmenopausal women
  83. Article focuses on new optical tools that use laser beams to peer painlessly below th
  84. New anti-tumor compounds show promise for hard-to-treat cancers
  85. LCA calls for more aggressive integration of imaging advances and biomedical research
  86. New imaging technology may pinpoint subtle aberrations in molecular biosignature of c
  87. PCI Biotech focuses on localised cancer therapy with minimum side effects
  88. Drinking red wine in moderation may reduce risk of breast cancer
  89. Prospective surveillance model can reduce treatment costs for breast cancer-related l
  90. Employees at Virginia Commerce Bank complete 12-week 'Stepitup' fitness program
  91. Study shows high consistency of malignancy-risk gene signature on both breast cancer
  92. Argentine Leader Is Told Thyroid Was Cancer-Free
  93. Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours
  94. Many parents share BRCA1/A2 test results with their children
  95. HDC, NeoGenomics sign worldwide licensing agreement to develop LDT
  96. CINJ receives grant to support its Breast Surgery Fellowship Program
  97. Neomatrix, UND partner to develop technology for early detection of breast cancer
  98. Obesity linked to higher rates of cancer screening across race/ethnicity and gender
  99. New possibilities for effective treatment of psoriasis
  100. Inherited breast and ovarian cancer drug trial re-launched in tablet form
  101. Erlotinib better for treatment of non-small cell lung cancers associated with altered
  102. Study reveals need for improvements in decision-making process for breast cancer surg
  103. Elevated ISG15 pathway may provide therapeutic targets for breast cancer
  104. Low-glycemic-load diet reduces C-reactive protein associated with chronic disease
  105. New imaging probes can non-invasively detect breast cancer lymph node metastasis
  106. Links between deodorants and breast cancer refuted but more information needed: Study
  107. Combination of lapatinib and trastuzumab more effective in treating HER2-positive bre
  108. BJALCF receives $1 million in grants for 2012 Lung Cancer Research
  109. Researchers develop simple process for synthesis of artemisinin
  110. Scientists identify hepsin protein's role in breast cancer
  111. Research reports on effectiveness of Scriptaid in breast cancer cell lines
  112. Scientists use gold-filled silicon wafers to target and burn breast cancer cells
  113. Researchers discover changes that cause tumor progression and metastasis
  114. Scientists identify pathway that activates hepsin on the surface of breast tumor cell
  115. HRT and breast cancer – the link questioned as study flaws are reported
  116. State roundup: Single-payer plans in Calif., Vt.; Calif. may regain state prison heal
  117. First study to examine years of life lost in Brisbane climate change
  118. Economic burden of job-related injuries and illnesses in the U.S.
  119. HOXB13 gene mutation linked to familial prostate cancer risk
  120. Clues about how statins might treat breast cancer
  121. About half of eligible and due services are missed during PHEs
  122. Novel nano-carrier platform shows promise for cancer drug delivery
  123. Novel imaging platform reveals new details on aggressive cancer development
  124. Red wine could play a role in lowering risk of breast cancer
  125. Exercise fails to improve glucose metabolism in autophagy-deficient mice
  126. Younger women with breast cancer experience a decrease in their health-related QOL
  127. Study describes new pharmacological resistance to colon cancer
  128. Researchers discover 13 new regions of genome associated with timing of menopause
  129. Researchers uncover 13 novel genetic loci linked with onset of menopause
  130. Power3, Amarantus sign license agreement for NuroPro Blood Test for Parkinson's
  131. Younger breast cancer survivors face more serious mental issues
  132. Society of Toxicology 51st Annual Meeting and ToxExpo to be held March 11-15
  133. Ovarian cancer patients with BRCA1 or BRCA2 mutations more likely to survive
  134. Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer
  135. Rotational motion plays a critical role in ability of breast cells to form acini
  136. Susan Mallery finds breakthrough treatment for oral cancer
  137. Patients may not receive all necessary screening tests during medical checkups
  138. Helios Berlin Buch acquires Mobetron for Intra-Operative Electron Radiation Therapy
  139. Circadian's VGX-100 human antibody improves corneal graft survival
  140. ASI's GenASIs for detection of chromosomal aberrations in bladder cancer receives FDA
  141. FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds
  142. Fat grafting may reduce radiation-induced complications in breast implants
  143. Fewer getting screened for common cancers: CDC report
  144. Cedars-Sinai Heart Institute to mark National Go Red for Women Day
  145. Hologic first quarter revenues increase 9.3% to $472.7 million
  146. Capital Health installs GE Discovery NM 750b scanner at N.J. Hopewell medical center
  147. Anti-HER2 dendritic cell vaccine shows promise against DCIS
  148. A question ...
  149. Breast cancer survivors use at-home method to prep their breasts for reconstruction
  150. Milestone for Starpharma's drug delivery program
  151. Majority of women fail to follow recommended MRI breast screening
  152. Nearly one in four women have another surgery following partial mastectomy
  153. General anesthesia may lower recurrence risk in patients with HCC
  154. Study reveals substantial differences in rates of follow-up surgeries after partial m
  155. New York hospital offers at-home method for tissue expansion for breast reconstructio
  156. Widely varying rates of repeat breast cancer surgery among surgeons: Study
  157. Metformin as cancer prevention
  158. Cancer Genomics now available online
  159. Komen Breast Cancer Foundation cuts grants, ties to Planned Parenthood
  160. Scientists Transform Deadly Plant Into Cancer Killing Smart Bomb
  161. Uproar follows Komen-Planned Parenthood rift
  162. Viewpoints: Censoring flu research; Assailing Komen's move to cut Planned Parenthood
  163. Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-s
  164. MD Anderson study takes on defining value in health care
  165. Rinse, repeat
  166. Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC
  167. Positive updated results from Aeterna Zentaris' AEZS-108 Phase 1 trial on CRPC
  168. VuCOMP receives PMA for M-Vu CAD system
  169. Soy isoflavone supplements do not reduce breast cancer cell proliferation
  170. New approach can solve treatment-resistant problem in cancers
  171. Road Hockey To Conquer Cancer to kick off sophomore campaign on Feb. 7
  172. Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails H
  173. Komen Foundation seeks to restore public support after ending cuts to Planned Parenth
  174. At local level, Komen affiliates express concern about decision
  175. Komen denies cut in Planned Parenthood funding was political
  176. EntreMed receives $9.3 million in strategic financing
  177. First Edition: February 6, 2012
  178. Body's zinc control mechanisms may be key to aggressive breast cancer treatments
  179. Viewpoints: Komen's retreat; Romney's selected support of Medicare cuts; Heritage ref
  180. Genomic Health plans to establish wholly owned subsidiary
  181. Researchers reveal how molecular imaging can solve breast cancer mysteries
  182. Komen Foundation works to regain balance in the wake of Planned Parenthood funding fl
  183. Cyclin D1 oncogene may promote chromosomal instability
  184. Women with higher mammographic density more likely to develop breast cancer
  185. Girls, 13, given contraceptive implants at school
  186. Roche’s new breast cancer drug Pertuzumab up for FDA review
  187. Viewpoints: GOP dragging heels on payroll tax, doc fix plan; Opinions still heated on
  188. FDA accepts Genentech's pertuzumab BLA and grants Priority Review
  189. Increasing age associated with higher risk of death from breast cancer
  190. Scientists study organ development in mice to unravel how breast cancers develop in p
  191. Researchers discover molecules that differentiate early-stage breast tumors from inva
  192. ACR, AdMeTech and ESUR to expedite development of standards for MR PI-RADS
  193. Exemestane has negative effect on postmenopausal women's bone health
  194. DF/CHCC specialists recommend genetic counseling for children with Li-Fraumeni syndro
  195. Komen vice president resigns
  196. Fasting and chemotherapy drugs more effectively treat cancers
  197. Road Hockey To Conquer Cancer to raise funding for personalized medicine
  198. Two new cancer research laboratories at WEHI receive $2M ACRF funding
  199. Injecting MWCNTs can kill tumor initiating breast cancer stem cells
  200. Komen's Brinker apologizes for 'how we mishandled this situation'
  201. Curcumin may block growth of castrate-resistant prostate tumors
  202. People with Lynch syndrome face increased risks of breast and pancreatic cancers
  203. Marshall University researcher to understand connections between cancer and obesity
  204. Radiation induces testicular cancer in male fetuses
  205. Surgery causes musculoskeletal alterations in breast cancer patients
  206. Radiation treatment transforms breast cancer stem cells into new iBCSCs
  207. Study confirms increased risk of cancers linked with Lynch syndrome
  208. mRNA sequencing reveals transcriptomic landscape of breast cancer
  209. Steady increase in Low Molecular Weight Heparin use for blood clots: Study
  210. Researchers investigate role of a MYC family gene in ovarian cancer
  211. Study finds BRCA1 mutations in nearly one in five TN breast cancer patients
  212. Ovarian cancer subtype may be susceptible to 'anti-angiogenic' drugs
  213. TFF3 protein plays a more sinister role in breast cancer metastasis
  214. Thrombocytosis linked to severity of ovarian cancer
  215. Women with cancer have worse health behaviors after mammography
  216. AstraZeneca launches ARIMIDEX Direct to help cancer patients
  217. Collaborative Cross can help fast-track key discoveries about genetics and disease
  218. Study details how breast tumors may flip TGF-beta signalling switch
  219. New process can transform discarded human fat into soft-tissue substitute
  220. Penn oncologist to discuss role of autophagy in fighting cancer at AAAS annual meetin
  221. ASI receives FDA clearance for GenASIs Scan and Analysis
  222. Charité launches new EU research project to personalize breast cancer treatment
  223. GTx fourth quarter net loss increases to $10.7 million
  224. Biotech company defends patent on gene mutation for breast cancer
  225. University of Pennsylvania, IMUC enter license agreement for dendritic-cell productio
  226. Targeting versican protein may help stop breast cancer metastasis
  227. High Court extends time allocated for health law arguments
  228. New kind of on-off switch for cortisol release in the brain discovered
  229. Women over 40 have better prognosis after mammography screening
  230. UCSF: 1-2 punch blocks tumor growth, invasion and metastasis
  231. Two-target approach may effectively stop pancreatic cancer metastasis
  232. First patients in Germany treated with Delcath Hepatic CHEMOSAT Delivery System
  233. FDA grants 510(k) clearance for Ventana Ki-67 image analysis algorithm
  234. Study finds subtle cognitive deficits in women treated with CMF chemotherapy
  235. FDA panel schedules review for U-Systems' somo•v ABUS system
  236. XL888 inhibitor can prevent vemurafenib resistance in melanoma patients
  237. Maturitas publishes EMAS' clinical guide on SERMs against postmenopausal osteoporosis
  238. EpiCept fourth quarter revenue decreases to $0.2 million
  239. Quitting hormone therapy can lead to breast tumor regression
  240. Cancer survival rates on the rise in Northern Ireland
  241. SWHR, NAMS encourage women to understand benefits and risks of hormone therapy
  242. On-site pathology evaluations cut operating time, reduce costs of breast cancer care
  243. Bayer receives FDA approval for lower dose formulation of ANGELIQ
  244. Loss of STAT1 transcription factor causes breast cancer development
  245. SIR to showcase latest minimally invasive treatments at 37th annual meeting
  246. 1.3 million cancer deaths in 2012 in the EU: Report
  247. Serum taurine may protect against CHD in women with high cholesterol
  248. March issue of WHO Bulletin available online
  249. Older women face increased risk of late stage breast cancer diagnosis
  250. Early surgical intervention stops seizures and improves quality of life